FDA warns of blood pressure med shortage

FDA Commissioner Scott Gottlieb and CDER Director Janet Woodcock released a statement warning of a shortage of ARBs, or angiotensin II receptor blockers, which contain valsartan.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news